Matches in Wikidata for { <http://www.wikidata.org/entity/Q83916787> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q83916787 description "article scientifique publié en 2012" @default.
- Q83916787 description "artículu científicu espublizáu n'abril de 2012" @default.
- Q83916787 description "scientific article published on 16 April 2012" @default.
- Q83916787 description "wetenschappelijk artikel" @default.
- Q83916787 description "наукова стаття, опублікована у квітні 2012" @default.
- Q83916787 name "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 name "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 type Item @default.
- Q83916787 label "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 label "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 prefLabel "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 prefLabel "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 P1433 Q83916787-C2FFCA1E-1870-4816-99BE-2EC8C9A140AD @default.
- Q83916787 P1476 Q83916787-F4E2B5DD-C6BF-488C-B71D-8BB6CD08FDEC @default.
- Q83916787 P2093 Q83916787-3450A76B-8AB2-4AC4-B43F-5F3B7E969AD6 @default.
- Q83916787 P2093 Q83916787-713474C4-6D74-4FA0-92B4-CE917F84DE10 @default.
- Q83916787 P304 Q83916787-3CF30237-5372-4491-9BF6-958EA9A9035A @default.
- Q83916787 P31 Q83916787-76315119-E11E-4E51-BE10-40AED5451D2E @default.
- Q83916787 P356 Q83916787-CD15E684-C096-483E-9AA2-B2051B0F1F34 @default.
- Q83916787 P433 Q83916787-CDE058A4-8143-460B-94DE-220E0E2EC35F @default.
- Q83916787 P478 Q83916787-73A8E160-4475-4E8D-8A4E-E0C007918D27 @default.
- Q83916787 P50 Q83916787-9A476343-00A3-4664-9111-2C3F23A6680A @default.
- Q83916787 P50 Q83916787-E3FEA35D-454E-426A-BAEC-DA20493CC50E @default.
- Q83916787 P577 Q83916787-B4EF3B67-39A4-4CD7-B0BB-FE6C77175243 @default.
- Q83916787 P698 Q83916787-8318F289-80A7-4473-82AA-D55F8508C305 @default.
- Q83916787 P356 EJE-12-0121 @default.
- Q83916787 P698 22511808 @default.
- Q83916787 P1433 Q3060778 @default.
- Q83916787 P1476 "Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment" @default.
- Q83916787 P2093 "Rabhat Shabani" @default.
- Q83916787 P2093 "Sabina Zacharieva" @default.
- Q83916787 P304 "17-25" @default.
- Q83916787 P31 Q13442814 @default.
- Q83916787 P356 "10.1530/EJE-12-0121" @default.
- Q83916787 P433 "1" @default.
- Q83916787 P478 "167" @default.
- Q83916787 P50 Q43102572 @default.
- Q83916787 P50 Q59788350 @default.
- Q83916787 P577 "2012-04-16T00:00:00Z" @default.
- Q83916787 P698 "22511808" @default.